recent
studw
provid
physicochem
electron
microscop
evid
exist
oftwo
distinct
agent
posttransfus
nona
nonb
nanb
hepat
one
agent
chloroformresist
associ
format
uniqu
ultrastructur
structur
infect
liver
agent
chci
sensit
induc
formatlon
characterist
hrpatocyt
cytoplasmlc
tubul
interfer
concurrrnt
hav
hbv
infect
experiment
inocul
chimpanze
tubuleform
agent
tfa
also
shown
pass
nm
capillari
porr
membran
filter
suggest
small
envelop
lipidcontain
wru
tfa
also
br
recov
iou
titer
io
infecti
dosesml
chronicphaw
chimpanze
plasma
use
multistep
purificatmn
procedur
assum
agent
small
envelop
rna
vnu
approxim
buoyant
densiti
gcm
sediment
corffici
thr
appar
lack
nucleic
acid
homolog
nanbtfa
hbv
suggest
nanbtfa
either
togavirusllk
belong
anoth
yet
undetin
class
rna
dna
viru
nona
nonb
viral
hepat
chloroformresist
agent
chci
sensitl
agent
lntroductlon
term
nona
nonb
nanb
hepat
use
classif
liver
diseas
caus
commonli
recogn
agent
name
hav
hbv
delta
cmv
ebv
exot
hepatotroph
virus
ebola
lassa
marburg
rift
valley
fever
recent
year
fact
even
becom
necessari
distinguish
nanb
hepat
agent
primarili
transmit
contamin
blood
blood
product
contrast
associ
fecallycontamin
drink
water
largescal
epidem
follow
overview
briefli
describ
pathogenet
featur
posttransfus
nanb
hepat
discuss
natur
put
etiolog
agent
approxim
transfus
individu
us
develop
acut
nanb
hepat
gener
symptomat
mild
anicter
natur
alter
et
al
report
prospect
follow
pth
case
persist
intermitt
alt
elev
yr
yr
spite
appar
benign
cours
acut
nanbpth
histolog
followup
nanb
patient
persist
alt
elev
reveal
chronic
activ
persist
hepat
frequent
develop
furthermor
nanbpth
patient
undergo
liver
biopsi
composit
pth
studi
cirrhosi
histolog
confirm
alter
thu
infect
least
one
agent
nanbpth
appear
lead
chronic
sequela
signific
proport
case
viruslik
natur
etiolog
agent
nanbpth
strongli
support
sever
line
experiment
retrospect
evid
includ
transmiss
diseas
human
andor
chimpanze
intraven
inocul
infect
blood
blood
fraction
purifi
chronicphas
plasma
prepar
alter
tabor
bradley
bradley
bradley
bradley
wyke
yoshizawa
infect
associ
least
one
agent
pth
destroy
treatment
chci
bradley
feinston
treatment
formalin
tabor
heat
min
yoshizawa
h
tabor
gereti
recent
studi
also
shown
chci
sensit
agent
pass
nm
filter
recov
chronicphas
plasma
use
procedur
suitabl
purif
small
envelop
virus
bradley
press
final
hepatocyt
ultrastructur
chang
observ
chimpanze
infect
least
one
major
agent
nanbpth
ident
similar
associ
vivo
replic
certain
class
rna
dna
virus
see
notion
nanbpth
caus
collect
serolog
unrel
hepatotroph
agent
deriv
observ
multipl
attack
hepat
patient
transfus
blood
product
mosley
hrubi
schauf
norkran
occurr
long
shortincub
period
diseas
transfus
patient
crask
aach
guyer
observ
uniqu
distinct
altpattern
infect
patient
tateda
result
crosschalleng
studi
chimpanze
experiment
infect
proveninfecti
materi
includ
blood
blood
product
bradley
holling
tsiquay
yoshizawa
appear
uniqu
distinct
ultrastructur
chang
infect
chimpanze
hepatocyt
shimizu
yoshizawa
bradley
observ
multipl
sequenti
episod
diseas
chimpanze
follow
inocul
physicochem
distinct
nanb
hepat
agent
bradley
appear
correct
interpret
earlier
chimpanze
crosschalleng
studi
result
may
confound
effect
either
persist
infect
viral
interfer
former
case
second
bout
diseas
experiment
infect
chimpanze
may
due
exacerb
chronic
underli
infect
rather
induct
nascent
diseas
due
inocul
second
presum
etiolog
agent
pth
hand
appar
protect
previous
nanbinfect
chimpanze
infect
second
challeng
inoculum
distinct
agent
could
simpli
due
viral
interfer
rather
presenc
homolog
neutral
antibodi
regard
latter
possibl
also
import
note
homolog
reinocul
previous
infect
chimpanze
necessarili
use
method
identif
anim
neutral
protect
antibodi
sinc
reinocul
persist
infect
chimpanze
would
likelihood
induc
second
bout
diseas
experi
nanbinfect
chimpanze
past
yr
shown
three
condit
may
oper
evid
exist
two
distinct
agent
nanbpth
deriv
use
physicochem
defin
inocula
bradley
sinc
persist
diseas
andor
viremia
probabl
rule
rather
except
infect
individu
much
aforement
evid
exist
multipl
nanb
agent
consid
presumpt
chimpanze
transmiss
studi
conduct
laboratori
provid
unequivoc
evid
occurr
longterm
viremia
diseas
experiment
inocul
anim
fact
histolog
examin
serial
liver
biopsi
specimen
total
nanb
infect
chimpanze
reveal
evid
persist
liver
diseas
long
yr
inocul
bradley
bradley
import
note
anim
persist
intermitt
elev
alt
activ
concurr
em
chang
suggest
continu
liver
dysfunct
observ
suggest
presenc
hepat
lesion
may
sensit
marker
persist
nanb
hepat
either
elev
alt
activ
hepatocyt
ultrastructur
alter
persist
viremia
also
demonstr
six
nanbinfect
chimpanze
yr
infect
inocul
naiv
chimpanze
chronicphas
plasma
obtain
anim
bradley
interest
note
plasma
obtain
anim
normal
alt
activ
lack
hepatocyt
ultrastructur
evid
infect
ie
tubul
also
infecti
bradley
bradley
find
surpris
particularli
view
project
gereti
et
al
per
comm
alter
et
al
approxim
nanbpth
would
prevent
screen
blood
donor
elev
alt
activ
relat
find
persist
diseas
experiment
infect
chimpanze
recent
observ
elev
alt
activ
spontan
occur
even
prolong
period
normal
liver
enzym
bradley
exampl
two
chimpanze
acut
infect
factorviii
deriv
tubuleform
agent
tfa
develop
typic
biochem
hepatocyt
ultrastructur
evid
nanbpth
one
anim
appear
resolv
hepat
indic
normal
serum
alt
activ
loss
characterist
hepatocyt
cytoplasm
tubul
howev
yr
inocul
elev
alt
activ
hepatocyt
tubul
reappear
plasma
obtain
anim
yr
inocul
shown
caus
nanb
hepat
recipi
chimpanze
contradistinct
first
anim
second
chimpanze
demonstr
low
signific
persist
elev
alt
activ
accompani
presenc
hepatocyt
tubul
mth
inocul
anim
three
episod
sever
diseas
follow
mth
elev
alt
activ
found
close
parallel
prolifer
smooth
endoplasm
reticulum
ser
hepatocyt
tubul
combin
find
suggest
normal
alt
activ
disappear
hepatocyt
tubul
nanbinfect
chimpanze
necessarili
signal
recoveri
diseas
furthermor
result
also
strongli
impli
second
bout
nanb
hepat
chimpanze
may
actual
recrudesc
ofdiseas
due
chronic
underli
infect
parallel
cours
nanb
hepat
chimpanze
human
would
appear
total
resolut
diseas
may
occur
low
proport
infect
individu
phenomenon
viral
interfer
recent
document
chimpanze
simultan
infect
hbv
nanb
hav
nanb
bradley
brotman
tsiquay
studi
laboratori
reveal
profound
effect
persist
nanb
hepat
infect
superinfect
hav
neither
two
nanbinfect
chimpanze
persist
viremia
persist
intermitt
elev
alt
activ
develop
addit
elev
alt
activ
challeng
proveninfecti
hav
addit
challeng
anim
demonstr
delay
antihav
antibodi
respons
day
inocul
compar
control
chimpanze
day
inocul
receiv
inoculum
furthermor
neither
superinfect
chimpanze
shown
detect
hav
antigen
acutephas
liver
biopsi
specimen
daili
stool
specimen
one
possibl
except
one
anim
also
neg
ria
hav
ag
recent
also
found
chimpanze
biochem
electron
microscop
resolv
nanbpth
yr
may
also
demonstr
interfer
hav
superinfect
find
indic
even
presum
lowlevel
replic
nanb
tubuleform
agent
suffici
caus
signific
interfer
least
one
hepatotroph
viru
final
other
bradley
tsiquay
also
shown
acut
nanbpth
also
interfer
replic
hbv
hbsag
carrier
chimpanze
judg
decreas
surfac
antigen
titer
serum
hbv
dna
polymeras
activ
acutephas
nanb
diseas
coinfect
chimpanze
hbv
nanbtfa
also
found
delay
moder
obviat
appear
serolog
marker
hbv
infect
brotman
g
dolana
per
comm
clear
acut
persist
nanbpth
infect
capabl
interf
least
two
differ
hepatotrop
virus
howev
mechan
effect
respons
phenomenon
identifi
one
unusu
perhap
reveal
aspect
experiment
nanbpth
chimpanze
find
uniqu
ultrastructur
alter
hepatocyt
acut
persist
infect
anim
shimizu
bradley
bradley
bradley
pfeifer
chang
primarili
confin
hepatocyt
cytoplasm
fig
includ
format
peculiar
convolut
membran
erc
nm
diamet
tubul
compris
doubleunit
membran
enclos
yet
uncharacter
osmiophil
substanc
dens
reticular
inclus
bodi
structur
appear
result
prolifer
smooth
endoplasm
reticulum
ser
respons
infect
nanbtfa
fig
bundl
granular
microtubul
may
also
observ
infect
hepatocyt
structur
dissimilar
commonli
describ
smooth
microtubul
appear
compris
nm
diamet
stack
disk
fig
dens
reticular
inclus
bodi
refer
fibrillargranular
mass
highli
convolut
dens
stain
materi
may
fact
compris
microtubul
coat
amorph
osmiophil
substanc
mani
structur
contain
multipl
foci
radiat
strandlik
attach
surround
er
fig
latter
structur
somewhat
similar
viroplasm
foci
viru
factori
describ
mous
hepat
viru
rnacontain
coronaviru
davidferreira
manak
influenza
viru
compan
choppin
although
convinc
evid
virusspecif
associ
nucleic
acid
rna
nanb
dens
reticular
inclus
bodi
document
worth
note
one
group
investig
shimizu
et
al
per
comm
found
ebvtransform
peripher
lymphocyt
nanbinfect
chimpanze
produc
igm
antibodi
specif
bind
structur
present
unclear
whether
antibodi
recogn
virusor
hostspecif
antigen
bradley
x
ti
yet
none
irrefut
link
transmiss
diseas
put
viruslik
particl
vlp
shown
rang
diamet
nm
nm
includ
morpholog
similar
picornavirus
bradley
yoshizawa
hepadnavirus
hantz
togavirus
coursaget
recent
studi
gereti
et
al
per
comm
suggest
nanbtfa
may
retroviruslik
base
find
appar
specif
associ
revers
transcriptas
activ
nanb
infect
chcl
sensit
nanbtfa
see
document
propens
acut
diseas
progress
chronic
infect
would
appear
lend
support
assert
although
candid
agent
posttransfus
nanb
hepat
serologit
link
transmiss
human
diseas
sever
properti
one
viruslik
agent
infer
result
recent
anim
transmiss
studi
agent
associ
induct
hepatocyt
cytoplasm
tubul
sensit
chci
treatment
probabl
envelop
lipidcontain
viru
bradley
bradley
feinston
nanbtfa
also
shown
pass
nm
sharp
cutoff
polycarbon
membran
filter
bradley
press
indic
rel
small
envelop
lipidcontain
viru
nanbtfa
recent
recov
chronicphas
chimpanze
plasma
presum
low
titer
use
extens
purif
procedur
assum
agent
small
envelop
rna
viru
buoyant
densiti
cscl
sediment
coeffici
least
bradley
press
studi
laboratori
field
elsewher
fowler
princ
rule
similar
nanbtfa
hbv
sinc
nucleic
acid
hybrid
assay
even
condit
low
stringenc
reveal
presenc
signific
sequenc
homolog
agent
hbv
hepadnaviru
current
known
envelop
dna
viru
pass
nm
filter
consid
possibl
nanbtfa
envelop
rna
viru
known
envelop
rna
virus
belong
togaviru
class
readili
pass
nm
membran
filter
although
find
present
suggest
nanbtfa
togaviruslik
exclud
possibl
agent
belong
anoth
yet
undefin
class
rna
dna
viru
small
retroviru
also
recent
present
evid
exist
second
agent
nanbhepat
resist
chcl
treatment
bradley
agent
recov
either
chronic
phase
plasma
acutephas
liver
homogen
multistep
procedur
design
purif
picornavirus
second
presum
viral
agent
posttransfus
nanb
hepat
induc
format
uniqu
hepatocyt
tubul
erc
howev
extens
hepatocyt
cytoplasm
vesicul
vacuol
observ
infect
chimpanze
liver
biopsi
specimen
acut
phase
diseas
latter
ultrastructur
chang
similar
charact
found
cell
infect
picornavirus
combin
find
agreement
previou
recoveri
nm
viruslik
particl
proveninfecti
factor
viii
concentr
bradley
liver
chimpanze
first
second
primat
passag
factor
viiideriv
nanb
hepat
agent
maynard
bradley
final
nanb
hepat
agent
appear
associ
persist
viremia
presum
persist
hepat
diseas
sinc
chronicphas
plasma
factor
viiiinfect
chimpanze
found
contain
chcl
resist
chcl
sensit
agent
physicochem
pathogenet
properti
one
major
agent
human
pth
nanbtfa
summar
tabl
respect
pellet
plasma
assum
agent
u
agent
recov
chronicphas
plasma
byamultistep
procedur
use
purif
small
envelop
rna
virus
bradley
probabl
relat
low
titer
circul
viru
rel
defici
potent
nanb
igg
igm
antibodi
regard
former
issu
investig
found
human
chimpanze
inocufa
gener
titer
chimpanze
infecti
dose
cid
per
ml
exampl
factor
viii
agent
titer
less
cidml
bradley
nanb
f
strain
character
feinston
cowork
chronic
phase
human
plasma
titer
less
cidml
also
fibrinogen
prepar
describ
yoshizawa
cowork
titer
greater
less
cidml
acut
phase
h
strain
agent
anoth
plasma
describ
feinston
titer
cidml
chronicphas
plasma
one
nanb
carrier
chimpanze
recent
shown
titer
cidml
unpubl
find
caus
biochem
electron
microscop
evid
diseas
within
wk
inocul
suscept
anim
final
tabor
gereti
per
comm
found
one
nanb
inocula
titer
approxim
io
cidml
even
assum
time
defect
infect
virion
specimen
cidml
may
contain
detect
antigen
provid
hightit
antibodi
use
optim
immunoassay
procedur
chronic
carrier
nanb
hepat
normal
circul
viru
titer
less
idml
excess
solubl
virusspecif
antigen
present
serolog
test
consider
greater
sensit
requir
success
detect
particul
viral
antigen
possibl
altern
develop
convent
serolog
test
nanbpth
tabl
list
sever
newer
approach
mani
antibodi
independ
natur
make
use
diseaserel
phenomenon
viral
interfer
one
promis
techniqu
involv
possibl
detec
tion
diseasespecif
antibodi
produc
transform
lymphocyt
see
verifi
procedur
could
theoret
allow
identif
nanbinfect
blood
donor
serolog
analysi
vitro
transform
lymphocyt
obtain
individu
